Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition

European Journal of Immunology

Volumn 43, Issue 3, 2013, Pages 734-746

  Khan, Adnan ^a   Fu, Hongmei ^a   Tan, Lee Aun ^a   Harper, Jennifer E ^a   Beutelspacher, Sven C ^a   Larkin, Daniel F P ^b   Lombardi, Giovanna ^c   Mcclure, Myra O ^d   George, Andrew J T ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Corneal transplantation; Dendritic cells; Gene therapy; Tolerance induction; Transplantation tolerance

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HYBRID PROTEIN; LENTIVIRUS VECTOR; TRYPTOPHAN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLONAL ANERGY; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DENDRITIC CELL; ENDOPLASMIC RETICULUM; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; CELL SURVIVAL; CLONAL ANERGY; CORNEAL TRANSPLANTATION; CTLA-4 ANTIGEN; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; GENETIC VECTORS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOMODULATION; LENTIVIRUS; LYMPHOCYTE ACTIVATION; MICE; OLIGOPEPTIDES; PHENOTYPE; PROTEIN SORTING SIGNALS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TRANSDUCTION, GENETIC; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84874977195     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242914     Document Type: Article

References (53)

1. Morelli, A. E. and Thomson, A. W., Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 2007. 7: 610-621.
2. Mirenda, V., Berton, I., Read, J., Cook, T., Smith, J., Dorling, A. and Lechler, R. I., Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: an efficient way to induce indirect pathway regulation. J. Am. Soc. Nephrol. 2004. 15: 987-997.
3. Andreakos, E., Smith, C., Monaco, C., Brennan, F. M., Foxwell, B. M. and Feldmann, M., Ikappa B kinase 2 but not NF-kappa B-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction. Blood 2003. 101: 983-991.
4. Yoshimura, S., Bondeson, J., Brennan, F. M., Foxwell, B. M. and Feldmann, M., Antigen presentation by murine dendritic cells is nuclear factor-kappa B dependent both in vitro and in vivo. Scand. J. Immunol. 2003. 58: 165-172.
5. Munro, S. and Pelham, H. R., A C-terminal signal prevents secretion of luminal ER proteins. Cell 1987. 48: 899-907.
6. Tan, P. H., Yates, J. B., Xue, S. A., Chan, C., Jordan, W. J., Harper, J. E., Watson, M. P. et al., Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression. Blood 2005. 106: 2936-2943.
7. Stone, T. W. and Darlington, L. G., Endogenous kynurenines as targets for drug discovery and development. Nat. Rev. Drug Discov. 2002. 1: 609-620.
8. Moffett, J. R. and Namboodiri, M. A., Tryptophan and the immune response. Immunol. Cell Biol. 2003. 81: 247-265.
9. Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U. and Ferrara, G. B., Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase. J. Exp. Med. 2002. 196: 459-468.
10. Terness, P., Bauer, T. M., Rose, L., Dufter, C., Watzlik, A., Simon, H. and Opelz, G., Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 2002. 196: 447-457.
11. George, A. J. and Larkin, D. F., Corneal transplantation: the forgotten graft. Am. J. Transplant 2004. 4: 678-685.
12. Beutelspacher, S. C., Pillai, R., Watson, M. P., Tan, P. H., Tsang, J., McClure, M. O., George, A. J. et al., Function of indoleamine 2, 3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur. J. Immunol. 2006. 36: 690-700.
13. Fu, H., Khan, A., Coe, D., Zaher, S., Chai, J. G., Kropf, P., Muller, I. et al., Arginine depletion as a mechanism for the immune privilege of corneal allografts. Eur. J. Immunol. 2011. 41: 2997-3005.
14. Williams, K. A., Lowe, M., Bartlett, C., Kelly, T. L. and Coster, D. J., Risk factors for human corneal graft failure within the Australian corneal graft registry. Transplantation 2008. 86: 1720-1724.
15. Illigens, B. M., Yamada, A., Fedoseyeva, E. V., Anosova, N., Boisgerault, F., Valujskikh, A., Heeger, P. S. et al., The relative contribution of direct and indirect antigen recognition pathways to the alloresponse and graft rejection depends upon the nature of the transplant. Hum. Immunol. 2002. 63: 912-925.
16. Sano, Y., Streilein, J. W. and Ksander, B. R., Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway." Transplantation 1999. 68: 963-970.
17. Boisgerault, F., Liu, Y., Anosova, N., Dana, R. and Benichou, G., Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants. Transplantation 2009. 87: 16-23.
18. Fu, H., Larkin, D. F. and George, A. J., Immune modulation in corneal transplantation. Transplant Rev (Orlando) 2008. 22: 105-115.
19. Tan, P. H., Beutelspacher, S. C., Xue, S. A., Wang, Y. H., Mitchell, P., McAlister, J. C., Larkin, D. F. et al., Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood 2005. 105: 3824-3832.
20. Mellor, A. L., Chandler, P., Baban, B., Hansen, A. M., Marshall, B., Pihkala, J., Waldmann, H. et al., Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2, 3 dioxygenase. Int. Immunol. 2004. 16: 1391-1401.
21. Sherr, C. J. and Roberts, J. M., Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995. 9: 1149-1163.
22. + T cell proliferation and effector function. J. Immunol. 2005. 174: 3359-3368.
23. Sherman, L. A. and Chattopadhyay, S., The molecular basis of allorecognition. Annu. Rev. Immunol. 1993. 11: 385-402.
24. Warrens, A. N., Lombardi, G. and Lechler, R. I., Presentation and recognition of major and minor histocompatibility antigens. Transpl. Immunol. 1994. 2: 103-107.
25. Yeoman, H. and Mellor, A. L., Tolerance and MHC restriction in transgenic mice expressing a MHC class I gene in erythroid cells. Int. Immunol. 1992. 4: 59-65.
26. + T cell responses in vivo. Int. Immunol. 1996. 8: 351-358.
27. Ensminger, S. M., Spriewald, B. M., Witzke, O., Pajaro, O. E., Yacoub, M. H., Morris, P. J., Rose, M. L. et al., Indirect allorecognition can play an important role in the development of transplant arteriosclerosis. Transplantation 2002. 73: 279-286.
28. van Kooten, C., Lombardi, G., Gelderman, K. A., Sagoo, P., Buckland, M., Lechler, R. and Cuturi, M. C., Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities. Transplantation 2011. 91: 2-7.
29. Arce, F., Rowe, H. M., Chain, B., Lopes, L. and Collins, M. K., Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization. Mol. Ther. 2009. 17: 1643-1650.
30. Puk, O., Dalke, C., Favor, J., de Angelis, M. H. and Graw, J., Variations of eye size parameters among different strains of mice. Mamm. Genome. 2006. 17: 851-857.
31. John, S. W., Hagaman, J. R., MacTaggart, T. E., Peng, L. and Smithes, O., Intraocular pressure in inbred mouse strains. Invest. Ophthalmol. Vis. Sci. 1997. 38: 249-253.
32. De Vries, I. J., Krooshoop, D. J., Scharenborg, N. M., Lesterhuis, W. J., Diepstra, J. H., Van Muijen, G. N., Strijk, S. P. et al., Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 2003. 63: 12-17.
33. Tan, P. H., Beutelspacher, S. C., Wang, Y. H., McClure, M. O., Ritter, M. A., Lombardi, G. and George, A. J., Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination. Mol. Ther. 2005. 11: 790-800.
34. Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C. et al., The combined effects of tryptophan starvation and tryptophan catabolites downregulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 2006. 176: 6752-6761.
35. Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C. et al., Tryptophan catabolism generates autoimmune-preventive Treg cells. Transpl. Immunol. 2006. 17: 58-60.
36. +CD25-high Treg cells by promoting maturation of LPS-treated dendritic cells. Eur. J. Immunol. 2007. 37: 3054-3062.
37. Mellor, A. L. and Munn, D. H., Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol. Today 1999. 20: 469-473.
38. Hamrah, P., Zhang, Q., Liu, Y. and Dana, M. R., Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest. Ophthalmol. Vis. Sci. 2002. 43: 639-646.
39. Liu, Y., Hamrah, P., Zhang, Q., Taylor, A. W. and Dana, M. R., Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J. Exp. Med. 2002. 195: 259-268.
40. + T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival. Invest. Ophthalmol. Vis. Sci. 2011. 52: 2640-2648.
41. Lechler, R. I., Garden, O. A. and Turka, L. A., The complementary roles of deletion and regulation in transplantation tolerance. Nat. Rev. Immunol. 2003. 3: 147-158.
42. Bienemann, A. S., Martin-Rendon, E., Cosgrave, A. S., Glover, C. P., Wong, L. F., Kingsman, S. M., Mitrophanous, K. A. et al., Long-term replacement of a mutated nonfunctional CNS gene: reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin. Mol. Ther. 2003. 7: 588-596.
43. Beutelspacher, S. C., Ardjomand, N., Tan, P. H., Patton, G. S., Larkin, D. F., George, A. J. and McClure, M. O., Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction. Exp. Eye Res. 2005. 80: 787-794.
44. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. et al., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.
45. Lutz, M. B., Kukutsch, N., Ogilvie, A. L., Rossner, S., Koch, F., Romani, N. and Schuler, G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999. 223: 77-92.
46. Zal, T., Volkmann, A. and Stockinger, B., Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 1994. 180: 2089-2099.
47. Tan, P. H., Manunta, M., Ardjomand, N., Xue, S. A., Larkin, D. F., Haskard, D. O., Taylor, K. M. et al., Antibody targeted gene transfer to endothelium. J. Gene Med. 2003. 5: 311-323.
48. Tan, P. H., Sagoo, P., Chan, C., Yates, J. B., Campbell, J., Beutelspacher, S. C., Foxwell, B. M. et al., Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates Treg cells. J. Immunol. 2005. 174: 7633-7644.
49. Marelli-Berg, F. M., Frasca, L., Imami, N., Lombardi, G. and Lechler, R. I., Lack of T cell proliferation without induction of nonresponsiveness after antigen presentation by endothelial cells. Transplantation 1999. 68: 280-287.
50. Takikawa, O., Kuroiwa, T., Yamazaki, F. and Kido, R., Mechanism of interferon-gamma action. Characterization of indoleamine 2, 3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J. Biol. Chem. 1988. 263: 2041-2048.
51. Feng, G. S. and Taylor, M. W., Interferon gamma-resistant mutants are defective in the induction of indoleamine 2, 3-dioxygenase. Proc. Natl. Acad. Sci. USA 1989. 86: 7144-7148.
52. Zhang, E. P., Schrunder, S. and Hoffmann, F., Orthotopic corneal transplantation in the mouse-a new surgical technique with minimal endothelial cell loss. Graefes Arch. Clin. Exp. Ophthalmol. 1996. 234: 714-719.
53. Ardjomand, N., McAlister, J. C., Rogers, N. J., Tan, P. H., George, A. J. and Larkin, D. F., Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Invest. Ophthalmol. Vis. Sci. 2003. 44: 3899-3905.